Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have sleep and mental health issues, especially if overweight or insulin resistant.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Women with PCOS often feel anxious and distressed about their appearance, especially in social situations.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Review determines effective, safe treatments for female hair loss.

Females with pattern hair loss have more occipital involvement than males.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Healthy women tend to lose more hair in July and April, and the least in February.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.